Fig. 4
From: BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes
Expression of BTLA and HVEM in cancerous tissues of patients with EOCs. a Representative figures of the expressions of BTLA, HVEM, and GAPDH in cancerous tissues detected by RT-PCR. The expression of BTLA was not detected in all tissues of EOCs. b Representative figures of the expressions of BTLA b1, HVEM b2 and β-actin b3 in cancerous tissues analyzed by qPCR. The numbers of cycles for amplification-generated fluorescence to detect HVEM and β-actin were all within 40, but those to identify BTLA were not. c Heat map of complete results of BTLA and HVEM levels in 254 cancerous samples by qPCR. Each row represents a sample and each column represents BTLA or HVEM levels. Relative expression levels of the two molecules were shown by colors and intensities. The blue indicates low, yellow for median and red for high